Navigation Links
Medivation Reports First Quarter 2009 Financial Results and Provides Corporate Update
Date:5/11/2009

cessary to ensure that each bears its applicable share of costs. For the first quarter of 2009, the true-up payment payable to Medivation was $5.8 million. Medivation presents these cost-sharing true-up payments in the applicable expense line of its statement of operations.

Medivation reported a net loss for the quarter ended March 31, 2009, of $5.6 million, or $0.19 per share, compared with a net loss of $15.5 million, or $0.54 per share, for the same period in 2008.

Cash, cash equivalents and short-term investments at March 31, 2009, totaled $200.7 million, compared with $221.4 million at December 31, 2008.

Conference Call Information

To participate in today's live call beginning at 4:30 p.m. Eastern Time by telephone, please call 877-681-3376 from the U.S. or +1-719-325-4757 internationally. In addition, the live conference call is being webcast and can be accessed on the "Events and Presentations" page of the "Investor Relations" section of the Company's website at www.medivation.com. A replay also will be available for 30 days following the live call.

About Medivation

Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel small molecule drugs to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their caregivers. In September 2008, Medivation announced a global agreement with Pfizer Inc to develop and commercialize Dimebon for the treatment of Alzheimer's and Huntington's diseases. With Pfizer, the Company is conducting a broad Dimebon clinical development program, including a pivotal and confirmatory Phase 3 trial, known as the CONNECTION study, in patients with mild-to-moderate Alzheimer's disease. The program also includes additional trials pla
'/>"/>

SOURCE Medivation, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Medivation to Announce Early Positive Data from Phase 1-2 Hormone Refractory Prostate Cancer Trial and Host Conference Call and Webcast on Monday, November 5, 2007
2. Medivation Plans to Initiate Pivotal Confirmatory Phase 3 Trial of Dimebon(TM) for Alzheimers Disease in Second Quarter of 2008
3. Medivation to Present at Cowen and Companys 28th Annual Health Care Conference
4. Medivation Announces Participation in Upcoming Conferences
5. Medivation Announces Participation in 27th Annual J.P. Morgan Healthcare Conference
6. Medivation Announces Participation in Upcoming Conferences
7. Medivation to Host Conference Call and Slide Presentation at 4:30 p.m. EST Wednesday, February 25, to Discuss New MDV3100 Efficacy and Safety Data From Trial in Castration-Resistant Prostate Cancer Patients
8. Medivation Announces Fourth Quarter and Year-End 2008 Teleconference and Webcast on March 16, 2009
9. Medivation Receives FDA Permission to Initiate Phase 3 Trial of MDV3100 in Castration-Resistant Prostate Cancer
10. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
11. Haemacure Reports Third Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... News) -- Including women older than 70 in national ... reduction in advanced forms of the disease, a new ... programs could result in older women being overdiagnosed and ... to screen older women for breast cancer should be ... of using mass screening, the decision to participate in ...
(Date:9/16/2014)... (PRWEB) September 16, 2014 Thousands ... against C.R. Bard, Inc. continue to move forward ... District Court, Southern District of West Virginia, Bernstein ... September 15, 2014, the Court has determined that ... the proceeding. The Order indicates that the first ...
(Date:9/16/2014)... Dennis Thompson HealthDay Reporter ... Food and Drug Administration is focusing on the "Low T" ... helping or harming the health of aging American males. ... FDA committees will discuss whether doctors are prescribing testosterone therapy ... hormone increases the risk of stroke and heart attack. ...
(Date:9/16/2014)... researcher Dr. Jeffrey Samet and Dr. Carlos Del ... five year, $5 million grant from the National ... Improving Physician Opioid Prescribing for Chronic Pain in ... most commonly abused substances in the U.S. (after ... now exceed deaths from motor vehicle crashes. Prescription ...
(Date:9/16/2014)... SAMHSA, the federal Substance Abuse and Mental Health Services Administration, ... substance abuse and mental health issues on the communities of ... National Recovery Month, also simply Recovery Month, with its main ... in recovery. It also seeks to educate Americans on ... help those with substance abuse issues live a healthy and ...
Breaking Medicine News(10 mins):Health News:Some Benefits of Screening Elderly Women for Breast Cancer Questioned 2Health News:Vaginal Mesh Lawsuit News: Discovery Conferences Scheduled for Federal Transvaginal Mesh Lawsuits Filed Against C.R. Bard, Bernstein Liebhard LLP Reports 2Health News:Vaginal Mesh Lawsuit News: Discovery Conferences Scheduled for Federal Transvaginal Mesh Lawsuits Filed Against C.R. Bard, Bernstein Liebhard LLP Reports 3Health News:Vaginal Mesh Lawsuit News: Discovery Conferences Scheduled for Federal Transvaginal Mesh Lawsuits Filed Against C.R. Bard, Bernstein Liebhard LLP Reports 4Health News:FDA to Probe Testosterone Therapy Claims, Safety 2Health News:FDA to Probe Testosterone Therapy Claims, Safety 3Health News:FDA to Probe Testosterone Therapy Claims, Safety 4Health News:Narconon Arrowhead Booklet Offers Tips During Recovery Month 2Health News:Narconon Arrowhead Booklet Offers Tips During Recovery Month 3
... the dentist for what you think is a routine checkup ... root canal. Though it,s a term you,ve probably heard before, ... have several questions and feel apprehensive about your upcoming procedure. ... time. The Pennsylvania Dental Association (PDA) wants to help answer ...
... , WASHINGTON, Nov. 12 Over the next several weeks, ... a major step toward improving food safety for all Americans. ... organizations and groups representing victims of foodborne illness is sending ... Safe for the Holidays!" , Every year, millions of Americans ...
... Nov. 12 /PRNewswire-FirstCall/ -- Mesa Laboratories, Inc. (Nasdaq: ... has declared a regular quarterly dividend of $.11 per share ... The dividend will be payable December 15, 2009, to ... public in 1984 Mesa Labs has maintained strong cash positions ...
... , WASHINGTON, Nov. 12 Senate Majority Leader Harry Reid ... quality, affordable health care for all. , The Associated Press ... under review is asking individuals who earn more than $250,000 ... tax that goes to Medicare. This measure would bring in ...
... As hormone use declined, so did incidence of abnormal cells ... News) -- Declining use of hormone replacement therapy may be ... a known risk factor for breast cancer, new research suggests. ... found between atypical ductal hyperplasia -- abnormal cells in the ...
... new study published in the November issue of the ... breast cancer patients under 40 years old who undergo fertility ... of their disease when their care is coordinated in a ... surgeons, medical oncologists and reproductive endocrinologists is critical," said Lynn ...
Cached Medicine News:Health News:Painful Root Canals Are a Thing of the Past 2Health News:New Polls, Reports Highlight The Need To Update The U.S. Food Safety System And To 'Make Our Food Safe For The Holidays' 2Health News:New Polls, Reports Highlight The Need To Update The U.S. Food Safety System And To 'Make Our Food Safe For The Holidays' 3Health News:Reid Moves Toward Progressive Financing Measure to Help Fund Health Care Reform 2Health News:Less HRT, Fewer Cases of Possible Breast Cancer Precursor 2Health News:Less HRT, Fewer Cases of Possible Breast Cancer Precursor 3Health News:Fertility procedures need not delay breast cancer treatment for younger women 2
(Date:9/16/2014)... -- Chindex International, Inc. ("Chindex" or the "Company") (Nasdaq: ... meeting of stockholders held today, the Company,s stockholders adopted ... and among the Company, Healthy Harmony Holdings, L.P. ("Parent"), ... an affiliate of TPG, Shanghai Fosun Pharmaceutical (Group) Co., ... CEO of the Company. The Merger Agreement ...
(Date:9/16/2014)... KANSAS CITY, Kan. , Sept. 16, 2014 ... ), a pet therapeutics company focused on licensing, ... animals, today announced that it is commencing an ... common stock.  All of the shares are being ... LLC and Barclays are acting as joint book-running ...
(Date:9/16/2014)... , Sept. 16, 2014  This report analyzes the ... The report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ... , and Rest of World. Annual estimates and forecasts are ... historic analysis is provided for these markets. Market data and ...
Breaking Medicine Technology:Chindex Stockholders Approve Merger 2Chindex Stockholders Approve Merger 3Aratana Therapeutics, Inc. Announces Proposed Public Offering 2Global Digital Radiography Industry 2Global Digital Radiography Industry 3Global Digital Radiography Industry 4Global Digital Radiography Industry 5Global Digital Radiography Industry 6Global Digital Radiography Industry 7Global Digital Radiography Industry 8Global Digital Radiography Industry 9Global Digital Radiography Industry 10Global Digital Radiography Industry 11Global Digital Radiography Industry 12Global Digital Radiography Industry 13Global Digital Radiography Industry 14Global Digital Radiography Industry 15Global Digital Radiography Industry 16Global Digital Radiography Industry 17Global Digital Radiography Industry 18Global Digital Radiography Industry 19Global Digital Radiography Industry 20Global Digital Radiography Industry 21Global Digital Radiography Industry 22
... for inherited conditions, ROCHESTER, Minn., Sept. 11 ... can be used to regenerate,heart tissue to treat ... was expedited by the editors of Stem Cells ... journal,s Web site at, http://stemcells.alphamedpress.org/ ., The ...
... PURCHASE, N.Y., Sept. 11 Nutrition 21, ... marketer of nutritional supplements under,the Iceland Health ... manage blood sugar levels, improve cardiovascular health, ... today that study results,released by the National ...
Cached Medicine Technology:Stem Cell Regeneration Repairs Congenital Heart Defect 2Nutrition 21 Reports That National Toxicology Program Studies Support the Safety of Chromium Picolinate 2Nutrition 21 Reports That National Toxicology Program Studies Support the Safety of Chromium Picolinate 3Nutrition 21 Reports That National Toxicology Program Studies Support the Safety of Chromium Picolinate 4
Adjustable piston accommodates 7-9mm trephine blade. Complete punch includes base plate, piston carrier, piston for 7 - 9mm trephine blades and 18mm diameter Teflon block. Designed for accurate donor...
... German Craftsmanship have produced ... in the world. Ocutek® ... to you! Only holders ... certificate, which requires and ...
... of German Craftsmanship have ... instrumentation in the world. ... available to you! Only ... Meisterbrief certificate, which requires ...
... Centuries of German Craftsmanship ... surgical instrumentation in the ... them available to you! ... coveted Meisterbrief certificate, which ...
Medicine Products: